Parker Laboratories to launch ultrasound innovations at ENA 2023
Parker Laboratories Inc., an ultrasound supplies and accessories company, is launching two ultrasound products designed to increase patient safety, lower costs and improve workflow in busy healthcare settings like the emergency department. The company will introduce the UltraDrape II UGPIV Barrier and Securement Dressing and Tristel ULT high-level disinfectant foam at the upcoming annual meeting of the Emergency Nurses Association (ENA).
Ultrasound technologies offer important advantages for procedures such as inserting central lines and peripheral catheters, improving outcomes while also reducing risks and healthcare costs. Hospitals are seeing an increase in the number of patients with difficult vascular access (DiVA) that require ultrasound guidance to achieve peripheral vascular access. It is estimated there are 12 million ultrasound-guided peripheral IV (UGPIV) insertions performed annually in North America.
“As the use of ultrasound guidance in healthcare procedures increases, so does the need for supplies that make these procedures safer and more efficient, without increasing costs,” said Neal Buchalter, president of Parker Laboratories.
About UltraDrape II Barrier and Securement Dressing
UltraDrape II is the next generation of Parker’s groundbreaking UltraDrape, a dressing designed specifically for use during UGPIV procedures. Like the original, UltraDrape II is a sterile, dual-action barrier and securement dressing that provides a “gel-free” insertion site to decrease the risk of contamination and securement failure both during and after UGPIV procedures.
About Tristel ULT High-Level Disinfectant Foam
Tristel ULT is a high-level disinfectant that uses proprietary foam containing chlorine dioxide for reprocessing ultrasound probes. It was recently granted FDA clearance for use as a high-level disinfectant for ultrasound probes used within body cavities and for skin-surface transducers, making it the first product of its kind to be available in the United States.
More than 215 million ultrasound scans are performed in the U.S. each year, with approximately 20% of them requiring high-level disinfection. Tristel ULT disinfectant foam can be safely used on ultrasound probes, and it has been shown to be effective against pathogens ranging from SARS-CoV-2 to Mycobacterium tuberculosis.
ENA 2023 will take place September 21-23, 2023, in San Diego. To learn more about UltraDrape II and Tristel ULT, visit Parker Laboratories at BOOTH #1119.
